Analyst Consensus ?
ConsensusBuy43 ratings
Bullish3172.1%
Neutral1125.6%
Bearish12.3%
FN2 Earnings Intelligence
Danaher Corporation (DHR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 22, 2026 |
| Stifel | Buy | Buy | Maintain | Oct 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 22, 2026 |
| Baird | Outperform | Outperform | Maintain | Oct 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 13, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 5, 2026 |
| Guggenheim | Buy | Buy | Maintain | Oct 1, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jun 11, 2026 |
| HSBC | Buy | Buy | Maintain | Jun 3, 2026 |
| UBS | Buy | Buy | Maintain | Apr 22, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 13, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 29, 2026 |
| Rothschild & Co | Neutral | Buy | Downgrade | Oct 8, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 22, 2025 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Jul 11, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 3, 2025 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 31, 2024 |
| Stephens & Co. | Overweight | Overweight | Maintain | Oct 23, 2024 |
| Keybanc | Overweight | Overweight | Maintain | Oct 23, 2024 |
| Leerink Partners | Outperform | Outperform | Maintain | Jul 24, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 27, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 26, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 25, 2023 |
| Benchmark | Hold | Buy | Downgrade | Oct 24, 2022 |
| Needham | Buy | Buy | Maintain | Jul 27, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jan 31, 2020 |
| Argus Research | Buy | Buy | Maintain | Feb 1, 2018 |
| Argus | Buy | Buy | Maintain | Feb 1, 2018 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jun 7, 2017 |
| Janney Capital | Neutral | Buy | Downgrade | Jun 7, 2017 |
| Bernstein | Outperform | Market Perform | Upgrade | Jun 24, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Apr 25, 2016 |
| Sterne Agee | Neutral | Neutral | Maintain | Apr 25, 2016 |
| FBR Capital | Outperform | Market Perform | Upgrade | Nov 12, 2014 |
| ISI Group | Strong Buy | Buy | Upgrade | Apr 9, 2014 |
| S&P Capital IQ | Sell | Hold | Downgrade | Jan 17, 2014 |
| Bank of America | Buy | Neutral | Upgrade | Jan 14, 2014 |
| Ladenburg Thalmann | Buy | Buy | Maintain | Mar 4, 2013 |
| BMO Capital | Outperform | Outperform | Maintain | Jan 30, 2013 |
Upside is calculated against the persisted current price $232.97. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Douglas Schenkel | $260 | $233.57 | +11.6% | Oct 22, 2026 |
| Goldman Sachs | Analyst unavailable | $275 | $234.09 | +18.0% | Oct 22, 2026 |
| Robert W. Baird | Analyst unavailable | $254 | $234.09 | +9.0% | Oct 22, 2026 |
| Barclays | Analyst unavailable | $260 | $234.09 | +11.6% | Oct 22, 2026 |
| Morgan Stanley | Kallum Titchmarsh | $240 | $220.24 | +3.0% | Oct 12, 2026 |
| RBC Capital | Dan Leonard | $250 | $214.06 | +7.3% | Oct 5, 2026 |
| Guggenheim | Subbu Nambi | $250 | $220.34 | +7.3% | Oct 1, 2026 |
| UBS | Douglas Schenkel | $250 | $205.2 | +7.3% | Sep 9, 2026 |
| Deutsche Bank | Justin Bowers | $240 | $175.03 | +3.0% | Jul 22, 2026 |
| RBC Capital | Analyst unavailable | $215 | $179.14 | -7.7% | Jul 22, 2026 |
| Stifel Nicolaus | Daniel Arias | $220 | $179.14 | -5.6% | Jul 22, 2026 |
| Guggenheim | Analyst unavailable | $200 | $179.14 | -14.2% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $195 | $179.14 | -16.3% | Jul 22, 2026 |
| Evercore ISI | Vijay Kumar | $230 | $190.6 | -1.3% | Jul 6, 2026 |
| Piper Sandler | Analyst unavailable | $200 | $183.63 | -14.2% | Jun 11, 2026 |
| HSBC | Analyst unavailable | $230 | $176.11 | -1.3% | Jun 3, 2026 |
| RBC Capital | Analyst unavailable | $200 | $164.54 | -14.2% | May 14, 2026 |
| Jefferies | Tycho Peterson | $245 | $194.45 | +5.2% | Apr 21, 2026 |
| Robert W. Baird | Catherine Ramsey Schulte | $249 | $193.78 | +6.9% | Apr 17, 2026 |
| Redburn Partners | Analyst unavailable | $205 | $193.78 | -12.0% | Apr 17, 2026 |
| Barclays | Analyst unavailable | $230 | $195.87 | -1.3% | Apr 14, 2026 |
| Robert W. Baird | Analyst unavailable | $251 | $224.54 | +7.7% | Jan 29, 2026 |
| Jefferies | Analyst unavailable | $265 | $224.54 | +13.7% | Jan 28, 2026 |
| Evercore ISI | Vijay Kumar | $254 | $224.48 | +9.0% | Jan 28, 2026 |
| Argus Research | Analyst unavailable | $265 | $235.56 | +13.7% | Jan 14, 2026 |
| Evercore ISI | Vijay Kumar | $250 | $231.72 | +7.3% | Jan 5, 2026 |
| Wells Fargo | Analyst unavailable | $240 | $226.71 | +3.0% | Dec 15, 2025 |
| Goldman Sachs | Analyst unavailable | $265 | $224.48 | +13.7% | Dec 9, 2025 |
| Morgan Stanley | Analyst unavailable | $270 | $224.14 | +15.9% | Dec 1, 2025 |
| Wells Fargo | Analyst unavailable | $230 | $218.1 | -1.3% | Oct 23, 2025 |
| Robert W. Baird | Analyst unavailable | $247 | $220.77 | +6.0% | Oct 22, 2025 |
| Redburn Partners | Analyst unavailable | $220 | $208.77 | -5.6% | Oct 8, 2025 |
| RBC Capital | Analyst unavailable | $241 | $203.79 | +3.4% | Sep 2, 2025 |
| Scotiabank | Sung Ji Nam | $275 | $204.85 | +18.0% | Jul 11, 2025 |
| UBS | Dan Leonard | $240 | $196.31 | +3.0% | Apr 23, 2025 |
| Goldman Sachs | Matthew Sykes | $240 | $192.07 | +3.0% | Apr 22, 2025 |
| Robert W. Baird | Catherine Ramsey Schulte | $231 | $190.66 | -0.8% | Apr 16, 2025 |
| Stifel Nicolaus | Analyst unavailable | $260 | $210.74 | +11.6% | Mar 14, 2025 |
| Goldman Sachs | Matthew Sykes | $250 | $237.97 | +7.3% | Jan 15, 2025 |
| Guggenheim | Subbu Nambi | $275 | $228.66 | +18.0% | Dec 19, 2024 |
| Wolfe Research | Doug Schenkel | $285 | $242.32 | +22.3% | Oct 31, 2024 |
| KeyBanc | Paul Knight | $310 | $257.67 | +33.1% | Oct 23, 2024 |
| Robert W. Baird | Catherine Schulte | $277 | $261.28 | +18.9% | Oct 23, 2024 |
| Leerink Partners | Puneet Souda | $275 | $261.28 | +18.0% | Oct 23, 2024 |
| Stifel Nicolaus | Jacob Johnson | $315 | $273.62 | +35.2% | Oct 1, 2024 |
| Deutsche Bank | Justin Bowers | $270 | $236.08 | +15.9% | Apr 23, 2024 |
| HSBC | Rajesh Kumar | $280 | $240.34 | +20.2% | Apr 17, 2024 |
| Loop Capital Markets | Paul Knight | $300 | $247.44 | +28.8% | Sep 27, 2023 |
| Credit Suisse | Analyst unavailable | $300 | $266.37 | +28.8% | Jan 5, 2023 |
| Deutsche Bank | Analyst unavailable | $310 | $276.68 | +33.1% | Dec 14, 2022 |
| Barclays | Analyst unavailable | $277 | $261.16 | +18.9% | Nov 29, 2022 |
| UBS | Elizabeth Garcia | $297 | $291.47 | +27.5% | Jul 31, 2022 |
| RBC Capital | Deane Dray | $310 | $261.83 | +33.1% | Jun 1, 2022 |
| Robert W. Baird | Catherine Schulte | $319 | $248.14 | +36.9% | May 6, 2022 |
| Wells Fargo | Timothy Daley | $265 | $257.5 | +13.7% | Apr 29, 2022 |
| RBC Capital | Deane Dray | $299 | $250.98 | +28.3% | Apr 27, 2022 |
| Robert W. Baird | Catherine Schulte | $334 | $287.63 | +43.4% | Feb 6, 2022 |
| Goldman Sachs | Matthew Sykes | $360 | $281.11 | +54.5% | Jan 30, 2022 |
| Bernstein | Brendan Luecke | $365 | $293.31 | +56.7% | Jan 16, 2022 |
| Cowen & Co. | Daniel Brennan | $360 | $312.9 | +54.5% | Oct 22, 2021 |
| KeyBanc | Paul Knight | $345 | $312.9 | +48.1% | Oct 22, 2021 |
| Credit Suisse | Katie Tryhane | $370 | $329.26 | +58.8% | Sep 10, 2021 |
| Bank of America Securities | Derik De Bruin | $340 | $290.62 | +45.9% | Jul 23, 2021 |
| Benchmark Co. | Robert Wasserman | $330 | $284.16 | +41.6% | Jul 16, 2021 |
| Wolfe Research | Liza Garcia | $325 | $256.2 | +39.5% | Jun 18, 2021 |
| Morgan Stanley | Erin Wright | $288 | $256.2 | +23.6% | Jun 18, 2021 |
Track every rating change on DHR the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.